Journals / Nöropsikiyatri Arşivi / 2007 / Cilt: 44 - Sayı: 3

Hücre membranı antijenlerine karşı antikorlarla ilişkili limbik ensefalit

Limbic encephalitis associated with antibodies to cell membrane antigens

Pages
101–107
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Furthermore, this immunopehonotype associates less frequently with cancer or cytotoxic T cell infiltration than other limbic encephalitis variants and responds significantly better to immunosuppressive treatment methods.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Limbic encephalitis patients usually present with rapidly progressive memory deficit, psychiatric symptoms, seizures, CSF inflammatory findings and EEG or MRI abnormalities in the temporal lobes.
📊
Key Findings & Data:These antibodies are mainly directed against the cell membrane antigens such as voltage-gated potassium channels and N-methyl-D-aspartate receptors expressed by the hippocampal and cerebellar neuropil and play a significant pathogenic role.
💡
Conclusion & Impact:Furthermore, this immunopehonotype associates less frequently with cancer or cytotoxic T cell infiltration than other limbic encephalitis variants and responds significantly better to immunosuppressive treatment methods.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ensefalit · Tanı · ayırıcı

Abstract

Limbic encephalitis patients usually present with rapidly progressive memory deficit, psychiatric symptoms, seizures, CSF inflammatory findings and EEG or MRI abnormalities in the temporal lobes. While these findings might be caused by viral infections or systemic autoimmune disorders, many patients with limbic encephalitis have an immune-mediated etiology (paraneoplastic or not) characterized with serum or CSF antineuronal antibodies. Once considered rare, non-viral immune mediated limbic encephalitis is now increasingly recognized and new immunophenotypes are identified. With the advent of new diagnostic techniques, novel serum or CSF antibodies have been detected in the majority of limbic encephalitis patients previously regarded as seronegative. These antibodies are mainly directed against the cell membrane antigens such as voltage-gated potassium channels and N-methyl-D-aspartate receptors expressed by the hippocampal and cerebellar neuropil and play a significant pathogenic role. Furthermore, this immunopehonotype associates less frequently with cancer or cytotoxic T cell infiltration than other limbic encephalitis variants and responds significantly better to immunosuppressive treatment methods.

Özet

Limbik ensefalit hastaları genellikle hızlı ilerleyişli bellek kaybı, psikiyatrik semptomlar, nöbetler, inflamatuar BOS bulguları ve temporal loblarda EEG ve MR değişiklikleri ile başvururlar. Bu bulgulara viral enfeksiyonlar ve sistemik otoimmün hastalıklar da sebep olabilmekle beraber, pek çok limbik ensefalit hastasında serum veya BOS'da antinöronal antikorlarla karakterize immun-aracılı bir etiyoloji (paraneoplastik veya non-paraneoplastik) mevcuttur. Bir zamanlar nadir olduğu düşünülen non-viral immun-aracılı limbik ensefalit olgularına giderek daha fazla rastlanmakta ve yeni immünolojik fenotipler tanımlanmaktadır. Yeni tanı tekniklerinin ortaya çıkmasıyla, önceden seronegatif olduğu sanılan limbik ensefalit hastalarının çoğunda yeni serum veya BOS antikorları saptanmıştır. Bu antikorlar, büyük ölçüde, hipokampus ve serebellum nöropillerinde bulunan voltaj bağımlı potasyum kanalları ve N-metil-D-aspartat reseptörleri gibi hücre membranı antijenlerine karşı gelişmekte ve muhtemelen patojenik rol oynamaktadırlar. Ayrıca bu immünolojik fenotip diğer limbik ensefalit varyantlarına kıyasla kanser ve sitotoksik T hücresi infiltrasyonu ile daha az ilişkili olup immün sistemi baskılayıcı tedavi yöntemlerine daha iyi yanıt vermektedir.

🔖

Cite This Article

TÜZÜN, E. (2007). Hücre membranı antijenlerine karşı antikorlarla ilişkili limbik ensefalit. Nöropsikiyatri Arşivi, Cilt: 44 - Sayı: 3, 101–107. https://ajindex.com/articles/292905

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Brierley JB, Corsellis JAN, Hierons R, et al. Subacute encephalitis of later adult life. Mainly affecting the limbic areas. Brain 1960; 83:357-68
  2. Corsellis JA, Goldberg GJ, Norton AR. "Limbic encephalitis" and its association with carcinoma. Brain 1968; 91:481-96
  3. Bakheit AM, Kennedy PG, Behan PO. Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psychiatry 1990;53:1084-8
  4. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123:1481-94
  5. Alamowitch S, Graus F, Uchuya M, et al. Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain 1997;120:923-8
  6. Voltz R, Gultekin SH, Rosenfeld MR, et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 1999;340:1788-95
  7. Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001;50:73-8
  8. Lawn ND, Westmoreland BF, Kiely MJ, et al. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 2003;78:1363-8
  9. Espay AJ, Kumar V, Sarpel G. Anti-Hu-associated paraneoplastic limbic encephalitis presenting as rapidly progressive non-convulsive status epilepticus. J Neurol Sci 2006;246:149-52
  10. Dalmau J, Bataller L. Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders. Hematol Oncol Clin North Am 2006;20:1319-35
  11. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-12
  12. Thieben MJ, Lennon VA, Boeve BF, et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004;62:1177-82
  13. Kassubek J, Juengling FD, Nitzsche EU, et al. Limbic encephalitis investigated by 18FDG-PET and 3D MRI. J Neuroimaging 2001; 11:55-9
  14. Ances BM, Vitaliani R, Taylor RA, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 2005;128:1764-77
  15. Mathew RM, Vandenberghe R, Garcia-Merino A, et al. Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology 2007;68:900-5